Law360, New York (October 21, 2009) -- Efforts by drugmaker Teva Pharmaceuticals USA Inc. to dismiss rival Novartis Pharmaceuticals Corp.'s patent infringement suit over generic herpes medications have been stymied in federal court following a judge's ruling that he did not have sufficient information to decide whether the plaintiffs had proper standing to bring the case.
Judge Dennis M. Cavanaugh of the U.S. District Court for the District of New Jersey on Wednesday determined that an issue of fact remained as to whether Novartis subsidiaries owned...
